Skip to main content
Targeting FER kinase inhibits melanoma growth and metastasis
  • Iordanka A. Ivanova, Western University
  • Shinthujah Arulanantham, Western University
  • Kevin Barr, Western University
  • Mario Cepeda, Mayo Clinic
  • Katie M. Parkins, Western University
  • Amanda M. Hamilton, Western University
  • Danielle Johnston, Western University
  • Silvia Penuela, Western University
  • David A. Hess, Western University
  • John A. Ronald, Western University
  • Lina Dagnino, Western University
Document Type
Publication Date
URL with Digital Object Identifier

© 2019 by the authors. Licensee MDPI, Basel, Switzerland. Melanoma is one of the most aggressive types of tumors and exhibits high metastatic potential. Fes-related (FER) kinase is a non-receptor tyrosine kinase that has been implicated in growth and metastasis of various epithelial tumors. In this study, we have examined the role that FER kinase plays in melanoma at the molecular level. FER-depleted melanoma cells exhibit impaired Wnt/β-catenin pathway activity, as well as multiple proteomic changes, which include decreased abundance of L1-cell adhesion molecule (L1-CAM). Consistent with the pro-metastatic functions of these pathways, we demonstrate that depletion of FER kinase decreases melanoma growth and formation of distant metastases in a xenograft model. These findings indicate that FER is an important positive regulator of melanoma metastasis and a potential target for innovative therapies.

Citation Information
Iordanka A. Ivanova, Shinthujah Arulanantham, Kevin Barr, Mario Cepeda, et al.. "Targeting FER kinase inhibits melanoma growth and metastasis" Cancers Vol. 11 Iss. 3 (2019)
Available at: